Late endocrine-metabolic complications in survivors of young adult and adult-onset cancers: comprehensive evaluation and strategies for management. An Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD)
This paper highlights the importance of recognizing endocrine and metabolic complications, as well as identifying key risk factors that can suggest a more effective surveillance and management.
Authors
- Emanuela Arvat (ORCID: https://orcid.org/0000-0001-5689-4400)
- Matteo Verzè
- Rossella Mazzilli (ORCID: https://orcid.org/0000-0001-6707-3413)
- Dario Giuffrida (ORCID: https://orcid.org/0000-0001-6404-2304)
- Valerio Gristina (ORCID: https://orcid.org/0000-0002-2392-0470)
- Antongiulio Faggiano (ORCID: https://orcid.org/0000-0002-9324-3946)
- Antonella Argentiero
- Raffaella Buzzetti (ORCID: https://orcid.org/0000-0003-1490-6041)
- Gianluca Aimaretti (ORCID: https://orcid.org/0000-0002-6186-0106)
- Annalisa Natalicchio (ORCID: https://orcid.org/0000-0002-6131-7517)
- Stefania Gori (ORCID: https://orcid.org/0000-0001-6320-405X)
- Marco Gallo (ORCID: https://orcid.org/0000-0001-7166-0848)
- Angelo Avogaro (ORCID: https://orcid.org/0000-0002-1177-0516)
- Marzia Del Re (ORCID: https://orcid.org/0000-0001-7343-6161)
- Stella D’Oronzo (ORCID: https://orcid.org/0000-0002-1071-2058)
- Nicola Silvestris
- Alberto Ragni (ORCID: https://orcid.org/0000-0001-9278-8939)
- Laura Sciacca (ORCID: https://orcid.org/0000-0002-3258-7200)
- Maria Chiara Zatelli (ORCID: https://orcid.org/0000-0001-8408-7796)
- Matteo Monami (ORCID: https://orcid.org/0000-0001-9349-828X)
- Alessio Cortellini (ORCID: https://orcid.org/0000-0002-1209-5735)
- Francesco Giorgino (ORCID: https://orcid.org/0000-0001-7372-2678)
- Enzo Tuveri
- Stefano Fogli (ORCID: https://orcid.org/0000-0002-7845-2598)
- Valerio Renzelli
- Giampiero Marino
- Francesco Felicetti (ORCID: https://orcid.org/0000-0002-6642-8750)
- Monica Montagnani (ORCID: https://orcid.org/0000-0002-5697-8185)
- Fabrizio Stracci
- Francesco Perrone (ORCID: https://orcid.org/0000-0002-9738-0526)
- Tindara Franchina (ORCID: https://orcid.org/0000-0001-5920-4997)
- Lelio Morviducci
- Riccardo Candido (ORCID: https://orcid.org/0000-0003-2385-9160)
Institutions
- University of Pisa (IT)
- University of Messina (IT)
- Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
- University of Trieste (IT)
- Università Campus Bio-Medico (IT)
- University of Ferrara (IT)
- University of Perugia (IT)
- Fondazione Roma (IT)
- Hammersmith Hospital (GB)
- Agostino Gemelli University Polyclinic (IT)
- University of Catania (IT)
- Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT)
- ASL Roma (IT)
- Saint Camillus International University of Health and Medical Sciences (IT)
- Ospedale Sacro Cuore Don Calabria (IT)
- Ospedale di Santo Spirito (IT)
- Istituto Oncologico Veneto (IT)
- ATS Sardegna (Italy) (IT)
- Azienda Ospedaliera Sant'Andrea (IT)
- Istituto Tumori Bari (IT)
- LUM Jean Monnet University (IT)
- Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT)
- Campus Bio Medico University Hospital (IT)
- Ospedale Generale Regionale Francesco Miulli (IT)
- Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo (IT)
- Azienda Sanitaria Locale Roma 3 (IT)
- University of Florence (IT)
- Imperial College London (GB)
- University of Bari Aldo Moro (IT)
- Sapienza University of Rome (IT)
- University of Palermo (IT)
Publication Details
- Journal
- Journal of Endocrinological Investigation
- Published
- 2025-12-03
- DOI
- https://doi.org/10.1007/s40618-025-02764-5
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- Teva Pharmaceutical Industries
- Associazione Italiana di Oncologia Medica
- Regeneron Pharmaceuticals
- Les Laboratories Pierre Fabre
- Incyte
- European Foundation for the Study of Diabetes
- Novo Nordisk
- Astellas Pharma
- European Association for the Study of Diabetes
- Servier
- Ipsen
- Roche Diabetes Care
- Agenzia Italiana del Farmaco, Ministero della Salute
- Daiichi Sankyo Europe